National Cancer Institute; Notice of Meeting, 60383 [07-5242]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 205 / Wednesday, October 24, 2007 / Notices
Date: November 26–27, 2007.
Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Marriott Gaithersburg
Washingtonian Ctr., 204 Boardwalk Place,
Gaithersburg, MD 20878.
Contact Person: Gerald G. Lovinger, PhD.,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8101,
Bethesda, MD 20892–8329, 301–496–7987,
lovingeg@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: October 16, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5236 Filed 10–23–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
yshivers on PROD1PC62 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
President’s Cancer Panel.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be closed to the public in
accordance with the provisions set forth
in section 552b(c)(9)(B), Title 5 U.S.C.,
as amended, because the premature
disclosure of information and the
discussions would be likely to
significantly frustrate implementation of
recommendations.
Name of Committee: President’s Cancer
Panel.
Date: December 3, 2007.
Open: December 3, 2007, 7:30 a.m.–3:30
p.m.
Agenda: Strategies for Maximizing the
Nation’s Investment in Cancer.
Place: Ritz Carlton San Juan Hotel, 6961
Avenue of the Governors, Isla Verde,
Carolina, Puerto Rico 00979.
VerDate Aug<31>2005
15:33 Oct 23, 2007
Jkt 214001
Closed: December 3, 2007, 4 p.m.–6 p.m.
Agenda: Strategies for Maximizing the
Nation’s Investment in Cancer and discuss
potential topics for the 2008/2009 series.
Place: Ritz Carlton San Juan Hotel, 6961
Avenue of the Governors, Isla Verde,
Carolina, Puerto Rico 00979.
Contact Person: Abby Sandler, Ph.D.,
Executive Secretary, National Cancer
Institute, National Institutes of Health,
Building 6116, Room 212, 6116 Executive
Boulevard, Bethesda, MD 20892, 301/451–
9399.
Any interested person may file written
comments with the committee by forwarding
the comments to the Contact Person listed on
this notice. The comments should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: October 16, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5237 Filed 10–23–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
National Cancer Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in section
552b(6), as amended. The discussions
could disclose personal information
concerning NCI Staff and/or its
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
60383
contractors, the disclosure of which
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board.
Open: November 27, 2007, 8 a.m. to 4:45
p.m.
Agenda: Program reports and
presentations, Business of the Board.
Place: National Cancer Institute, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda,
Maryland 20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001,
Bethesda, Maryland 20892–8327, (301) 496–
5147.
Name of Committee: National Cancer
Advisory Board.
Closed: November 27, 2007, 4:45 p.m. to
5:30 p.m.
Agenda: Review intramural program site
visit outcomes; Discussion of confidential
personnel issues.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001,
Bethesda, Maryland 20892–8327, (301) 496–
5147.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/ncab.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398 Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: October 17, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5242 Filed 10–23–07; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\24OCN1.SGM
24OCN1
]]>Agencies
[Federal Register Volume 72, Number 205 (Wednesday, October 24, 2007)]
[Notices]
[Page 60383]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5242]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Cancer Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in section 552b(6), as amended. The
discussions could disclose personal information concerning NCI Staff
and/or its contractors, the disclosure of which constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board.
Open: November 27, 2007, 8 a.m. to 4:45 p.m.
Agenda: Program reports and presentations, Business of the
Board.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, Maryland 20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001, Bethesda, Maryland 20892-
8327, (301) 496-5147.
Name of Committee: National Cancer Advisory Board.
Closed: November 27, 2007, 4:45 p.m. to 5:30 p.m.
Agenda: Review intramural program site visit outcomes;
Discussion of confidential personnel issues.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001, Bethesda, Maryland 20892-
8327, (301) 496-5147.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398 Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: October 17, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5242 Filed 10-23-07; 8:45 am]
BILLING CODE 4140-01-M
